Investigational Drug Information for Varespladib methyl
✉ Email this page to a colleague
What is the development status for investigational drug Varespladib methyl?
Varespladib methyl is an investigational drug.
There have been 5 clinical trials for Varespladib methyl.
The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2010.
The most common disease conditions in clinical trials are Syndrome, Acute Coronary Syndrome, and Snake Bites. The leading clinical trial sponsors are Anthera Pharmaceuticals, Premier Research International LLC, and Ophirex, Inc.
Summary for Varespladib methyl
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 90 |
| WIPO Patent Applications | 85 |
| Japanese Patent Applications | 9 |
| Clinical Trial Progress | Phase 2 (2010-05-01) |
| Vendors | 30 |
Recent Clinical Trials for Varespladib methyl
| Title | Sponsor | Phase |
|---|---|---|
| Broad-spectrum Rapid Antidote: Varespladib Oral for Snakebite | Premier Research International LLC | Phase 2 |
| Broad-spectrum Rapid Antidote: Varespladib Oral for Snakebite | Ophirex, Inc. | Phase 2 |
| A Study of the Pharmacokinetics and Safety of Varespladib in Subjects With Normal or Impaired Renal Function | Anthera Pharmaceuticals | Phase 1 |
Clinical Trial Summary for Varespladib methyl
Top disease conditions for Varespladib methyl
Top clinical trial sponsors for Varespladib methyl
US Patents for Varespladib methyl
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
